大葉大學圖書館 |

Muscular dystrophy[electronic resource] :a concise guide /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.748
書名/作者:	Muscular dystrophy : a concise guide // edited by Raymond A. Huml.
其他作者:	Huml, Raymond A.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	xxiv, 191 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Neurology.
標題:	Pharmacotherapy.
標題:	Medicine/Public Health, general.
標題:	Muscular dystrophy.
標題:	Muscular dystrophy - Diagnosis.
標題:	Muscular dystrophy - Treatment.
標題:	Medicine & Public Health.
ISBN:	9783319173627 (electronic bk.)
ISBN:	9783319173610 (paper)
內容註:	1. Introduction to Muscular Dystrophy -- 2.Muscular Dystrophy: Historical Background and Types -- 3.FSHD: The Most Common Type of MD? -- 4.Duchenne and Becker Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms -- 5.An Overview of the Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms -- 6.Transition from Childhood to Adult in Patients with Muscular Dystrophy -- 7.Overview of Current Treatments for Muscular Dystrophy -- 8.Physical Therapy and Orthotic Devices for Patients with Muscular Dystrophy -- 9.Orthopedic Care of Children with Muscular Dystrophy -- 10.Global Regulatory Landscape -- 11.Key Challenges to the Approval of Products to Treat Patients with Muscular Dystrophy -- 12.Pharmaceutical Products and Non-Pharmaceutical Interventions as Potential Treatments for Patients with Muscular Dystrophy -- 13.US Patient Advocacy Groups -- 14.Global and National Patient Registries -- 15.Summary -- Index.
摘要、提要註:	This practical and concise guide offers an overview of muscular dystrophy's (MD) complicated features, treatment options and general resources. New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long-term patient care. Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances. Muscular Dystrophy: A Concise Guide offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient.
電子資源:	http://dx.doi.org/10.1007/978-3-319-17362-7

Muscular dystrophy[electronic resource] :a concise guide /
Muscular dystrophya concise guide /[electronic resource] :edited by Raymond A. Huml. - Cham :Springer International Publishing :2015. - xxiv, 191 p. :ill., digital ;24 cm.

1. Introduction to Muscular Dystrophy -- 2.Muscular Dystrophy: Historical Background and Types -- 3.FSHD: The Most Common Type of MD? -- 4.Duchenne and Becker Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms -- 5.An Overview of the Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms -- 6.Transition from Childhood to Adult in Patients with Muscular Dystrophy -- 7.Overview of Current Treatments for Muscular Dystrophy -- 8.Physical Therapy and Orthotic Devices for Patients with Muscular Dystrophy -- 9.Orthopedic Care of Children with Muscular Dystrophy -- 10.Global Regulatory Landscape -- 11.Key Challenges to the Approval of Products to Treat Patients with Muscular Dystrophy -- 12.Pharmaceutical Products and Non-Pharmaceutical Interventions as Potential Treatments for Patients with Muscular Dystrophy -- 13.US Patient Advocacy Groups -- 14.Global and National Patient Registries -- 15.Summary -- Index.

This practical and concise guide offers an overview of muscular dystrophy's (MD) complicated features, treatment options and general resources. New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long-term patient care. Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances. Muscular Dystrophy: A Concise Guide offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient.

ISBN: 9783319173627 (electronic bk.)

Standard No.: 10.1007/978-3-319-17362-7doiSubjects--Topical Terms:

402687
Neurology.

LC Class. No.: RC935.M7

Dewey Class. No.: 616.748

Muscular dystrophy[electronic resource] :a concise guide /
LDR:02492nam a2200313 a 4500 001 443203
003 DE-He213
005 20160218103840.0
006 m d
007 cr nn 008maaau
008 160715s2015 gw s 0 eng d
020 $a 9783319173627 (electronic bk.)
020 $a 9783319173610 (paper)
024 7 $a 10.1007/978-3-319-17362-7 $2 doi
035 $a 978-3-319-17362-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC935.M7
072 7 $a MJN $2 bicssc
072 7 $a MED056000 $2 bisacsh
082 0 4 $a 616.748 $2 23
090 $a RC935.M7 $b M985 2015
245 0 0 $a Muscular dystrophy $h [electronic resource] : $b a concise guide / $c edited by Raymond A. Huml.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xxiv, 191 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Introduction to Muscular Dystrophy -- 2.Muscular Dystrophy: Historical Background and Types -- 3.FSHD: The Most Common Type of MD? -- 4.Duchenne and Becker Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms -- 5.An Overview of the Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms -- 6.Transition from Childhood to Adult in Patients with Muscular Dystrophy -- 7.Overview of Current Treatments for Muscular Dystrophy -- 8.Physical Therapy and Orthotic Devices for Patients with Muscular Dystrophy -- 9.Orthopedic Care of Children with Muscular Dystrophy -- 10.Global Regulatory Landscape -- 11.Key Challenges to the Approval of Products to Treat Patients with Muscular Dystrophy -- 12.Pharmaceutical Products and Non-Pharmaceutical Interventions as Potential Treatments for Patients with Muscular Dystrophy -- 13.US Patient Advocacy Groups -- 14.Global and National Patient Registries -- 15.Summary -- Index.
520 $a This practical and concise guide offers an overview of muscular dystrophy's (MD) complicated features, treatment options and general resources. New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long-term patient care. Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances. Muscular Dystrophy: A Concise Guide offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient.
650 2 4 $a Neurology. $3 402687
650 2 4 $a Pharmacotherapy. $3 528865
650 2 4 $a Medicine/Public Health, general. $3 463494
650 0 $a Muscular dystrophy. $3 494237
650 0 $a Muscular dystrophy $x Diagnosis. $3 633664
650 0 $a Muscular dystrophy $x Treatment. $3 633665
650 1 4 $a Medicine & Public Health. $3 463493
700 1 $a Huml, Raymond A. $3 633663
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-17362-7
950 $a Medicine (Springer-11650)